Price Cuts For Daewoong As Korea Attacks Rebates
This article was originally published in PharmAsia News
Executive Summary
South Korea's Ministry of Health and Welfare will cut the prices of five products from Daewoong Pharmaceutical by 20% from May following a Seoul court's ruling last year that found the pharma firm guilty of providing illegal rebates in return for prescriptions.